Free tool
FAERS Monitor: Normosol-R In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017586 or its brand name (Normosol-R In Plastic Container, Magnesium Chloride, Potassium Chloride, Sodium Acetate, Sodium Chloride, Sodium Gluconate). Reports on generic versions are filed under their own applications.
Reports
30
Serious
26
87% of reports
Hospitalization
17
Death reported
9
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- metabolic acidosis5
- hyperkalaemia4
- acute kidney injury3
- hypoxia3
- sepsis3
- acute respiratory failure2
- ascites2
- cellulitis2
- fatigue2
- hyperglycaemia2
- intestinal perforation2
- paradoxical drug reaction2
- pyrexia2
- respiratory failure2
- septic shock2
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 10 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,129 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| paradoxical drug reaction | 2 | 381.3 | 99.9 | 426 |
| intestinal perforation | 2 | 124.9 | 32.7 | 138 |
| metabolic acidosisSignal | 5 | 109.6 | 49.3 | 436 |
| hyperkalaemiaSignal | 4 | 80.0 | 32.1 | 238 |
| acute respiratory failure | 2 | 72.9 | 19.1 | 79 |
| hypoxiaSignal | 3 | 59.7 | 20.4 | 120 |
| ascites | 2 | 47.7 | 12.5 | 51 |
| hyperglycaemia | 2 | 38.5 | 10.1 | 40 |
| septic shock | 2 | 32.2 | 8.4 | 33 |
| cellulitis | 2 | 27.8 | 7.3 | 28 |
| respiratory failure | 2 | 19.2 | 5.0 | 19 |
| sepsisSignal | 3 | 18.9 | 6.4 | 35 |
| acute kidney injurySignal | 3 | 13.7 | 4.7 | 24 |
| pyrexia | 2 | 4.1 | 1.1 | 2 |
| fatigue | 2 | 1.8 | 0.5 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.